Cargando…
A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
BACKGROUND AND OBJECTIVES: The ability to obtain adequate tissue of solid pancreatic lesions by EUS-guided remains a challenge. The aim of this study was to compare the performance characteristics and safety of EUS-FNA for evaluating solid pancreatic lesions using the standard 22-gauge needle versus...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838725/ https://www.ncbi.nlm.nih.gov/pubmed/29451167 http://dx.doi.org/10.4103/eus.eus_27_17 |
_version_ | 1783304293507399680 |
---|---|
author | Naveed, Mariam Siddiqui, Ali A. Kowalski, Thomas E. Loren, David E. Khalid, Ammara Soomro, Ayesha Mazhar, Syed M. Yoo, Joseph Hasan, Raza Yalamanchili, Silpa Tarangelo, Nicholas Taylor, Linda J. Adler, Douglas G. |
author_facet | Naveed, Mariam Siddiqui, Ali A. Kowalski, Thomas E. Loren, David E. Khalid, Ammara Soomro, Ayesha Mazhar, Syed M. Yoo, Joseph Hasan, Raza Yalamanchili, Silpa Tarangelo, Nicholas Taylor, Linda J. Adler, Douglas G. |
author_sort | Naveed, Mariam |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: The ability to obtain adequate tissue of solid pancreatic lesions by EUS-guided remains a challenge. The aim of this study was to compare the performance characteristics and safety of EUS-FNA for evaluating solid pancreatic lesions using the standard 22-gauge needle versus a novel EUS biopsy needle. METHODS: This was a multicenter retrospective study of EUS-guided sampling of solid pancreatic lesions between 2009 and 2015. Patients underwent EUS-guided sampling with a 22-gauge SharkCore (SC) needle or a standard 22-gauge FNA needle. Technical success, performance characteristics of EUS-FNA, the number of needle passes required to obtain a diagnosis, diagnostic accuracy, and complications were compared. RESULTS: A total of 1088 patients (mean age = 66 years; 49% female) with pancreatic masses underwent EUS-guided sampling with a 22-gauge SC needle (n = 115) or a standard 22-gauge FNA needle (n = 973). Technical success was 100%. The frequency of obtaining an adequate cytology by EUS-FNA was similar when using the SC and the standard needle (94.1% vs. 92.7%, respectively). The sensitivity, specificity, and diagnostic accuracy of EUS-FNA for tissue diagnosis were not significantly different between two needles. Adequate sample collection leading to a definite diagnosis was achieved by the 1(st), 2(nd), and 3(rd) pass in 73%, 92%, and 98% of procedures using the SC needle and 20%, 37%, and 94% procedures using the standard needle (P < 0.001), respectively. The median number of passes to obtain a tissue diagnosis using the SC needle was significantly less as compared to the standard needle (1 and 3, respectively; P < 0.001). CONCLUSIONS: The EUS SC biopsy needle is safe and technically feasible for EUS-FNA of solid pancreatic mass lesions. Preliminary results suggest that the SC needle has a diagnostic yield similar to the standard EUS needle and significantly reduces the number of needle passes required to obtain a tissue diagnosis. |
format | Online Article Text |
id | pubmed-5838725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-58387252018-03-09 A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions Naveed, Mariam Siddiqui, Ali A. Kowalski, Thomas E. Loren, David E. Khalid, Ammara Soomro, Ayesha Mazhar, Syed M. Yoo, Joseph Hasan, Raza Yalamanchili, Silpa Tarangelo, Nicholas Taylor, Linda J. Adler, Douglas G. Endosc Ultrasound Original Article BACKGROUND AND OBJECTIVES: The ability to obtain adequate tissue of solid pancreatic lesions by EUS-guided remains a challenge. The aim of this study was to compare the performance characteristics and safety of EUS-FNA for evaluating solid pancreatic lesions using the standard 22-gauge needle versus a novel EUS biopsy needle. METHODS: This was a multicenter retrospective study of EUS-guided sampling of solid pancreatic lesions between 2009 and 2015. Patients underwent EUS-guided sampling with a 22-gauge SharkCore (SC) needle or a standard 22-gauge FNA needle. Technical success, performance characteristics of EUS-FNA, the number of needle passes required to obtain a diagnosis, diagnostic accuracy, and complications were compared. RESULTS: A total of 1088 patients (mean age = 66 years; 49% female) with pancreatic masses underwent EUS-guided sampling with a 22-gauge SC needle (n = 115) or a standard 22-gauge FNA needle (n = 973). Technical success was 100%. The frequency of obtaining an adequate cytology by EUS-FNA was similar when using the SC and the standard needle (94.1% vs. 92.7%, respectively). The sensitivity, specificity, and diagnostic accuracy of EUS-FNA for tissue diagnosis were not significantly different between two needles. Adequate sample collection leading to a definite diagnosis was achieved by the 1(st), 2(nd), and 3(rd) pass in 73%, 92%, and 98% of procedures using the SC needle and 20%, 37%, and 94% procedures using the standard needle (P < 0.001), respectively. The median number of passes to obtain a tissue diagnosis using the SC needle was significantly less as compared to the standard needle (1 and 3, respectively; P < 0.001). CONCLUSIONS: The EUS SC biopsy needle is safe and technically feasible for EUS-FNA of solid pancreatic mass lesions. Preliminary results suggest that the SC needle has a diagnostic yield similar to the standard EUS needle and significantly reduces the number of needle passes required to obtain a tissue diagnosis. Medknow Publications & Media Pvt Ltd 2018 2018-02-15 /pmc/articles/PMC5838725/ /pubmed/29451167 http://dx.doi.org/10.4103/eus.eus_27_17 Text en Copyright: © 2018 Spring Media Publishing Co. Ltd http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Naveed, Mariam Siddiqui, Ali A. Kowalski, Thomas E. Loren, David E. Khalid, Ammara Soomro, Ayesha Mazhar, Syed M. Yoo, Joseph Hasan, Raza Yalamanchili, Silpa Tarangelo, Nicholas Taylor, Linda J. Adler, Douglas G. A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
title | A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
title_full | A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
title_fullStr | A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
title_full_unstemmed | A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
title_short | A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
title_sort | multicenter comparative trial of a novel eus-guided core biopsy needle (sharkcore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838725/ https://www.ncbi.nlm.nih.gov/pubmed/29451167 http://dx.doi.org/10.4103/eus.eus_27_17 |
work_keys_str_mv | AT naveedmariam amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT siddiquialia amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT kowalskithomase amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT lorendavide amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT khalidammara amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT soomroayesha amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT mazharsyedm amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT yoojoseph amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT hasanraza amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT yalamanchilisilpa amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT tarangelonicholas amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT taylorlindaj amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT adlerdouglasg amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT naveedmariam multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT siddiquialia multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT kowalskithomase multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT lorendavide multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT khalidammara multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT soomroayesha multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT mazharsyedm multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT yoojoseph multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT hasanraza multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT yalamanchilisilpa multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT tarangelonicholas multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT taylorlindaj multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions AT adlerdouglasg multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions |